RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in RVL Pharmaceuticals plc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
RVLP is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023
- Institutional holders
- 3
- −29 vs. Q3 2023
- Shares held
- 211.2K
- −17.9M (−98.8%) vs. Q3 2023
- Total value
- $613
- −$1.57M (−100.0%) vs. Q3 2023
- New holders
- 2
- 1 more added
- Sold out
- 31
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 180,566 | $542 | 0.00% | +180,566 | New |
| Raymond James & Associates | 23,696 | $71 | 0.00% | +23,696 | New |
| Simplex Trading, LLC | 6,900 | $0 | 0.00% | +5,278+325.4% | Added |
| Athyrium Capital Management, LP | 0 | $0 | 0.00% | −14,600,444−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −1,079,515−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −632,264−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −307,266−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −272,584−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −246,353−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −225,727−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −106,487−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −103,037−100.0% | Sold out |
| Titleist Asset Management, LLC | 0 | $0 | 0.00% | −100,142−100.0% | Sold out |
| Insight Advisors, LLC | 0 | $0 | 0.00% | −75,646−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −65,334−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −48,558−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −32,898−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −31,006−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −31,688−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −22,181−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −21,210−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −15,708−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −15,246−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −12,078−100.0% | Sold out |
| Williams Jones Wealth Management, LLC. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Dakota Community Bank & Trust NA | 0 | $0 | 0.00% | −1,809−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,720−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,187−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −590−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −2−100.0% | Sold out |